A detailed history of Neumann Capital Management, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Neumann Capital Management, LLC holds 6,685 shares of MRK stock, worth $749,254. This represents 0.28% of its overall portfolio holdings.

Number of Shares
6,685
Previous 6,685 -0.0%
Holding current value
$749,254
Previous $882,000 6.24%
% of portfolio
0.28%
Previous 0.31%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

BUY
$113.24 - $131.95 $203,832 - $237,509
1,800 Added 36.85%
6,685 $882,000
Q4 2023

Feb 07, 2024

BUY
$100.18 - $109.02 $12,021 - $13,082
120 Added 2.52%
4,885 $532,000
Q3 2022

Nov 14, 2022

BUY
$84.53 - $94.96 $2,789 - $3,133
33 Added 0.7%
4,765 $410,000
Q2 2022

Jul 20, 2022

BUY
$83.49 - $94.64 $4,174 - $4,732
50 Added 1.07%
4,732 $431,000
Q1 2022

May 09, 2022

BUY
$73.51 - $82.4 $9,188 - $10,300
125 Added 2.74%
4,682 $384,000
Q4 2021

Feb 03, 2022

BUY
$72.28 - $90.54 $7,228 - $9,054
100 Added 2.24%
4,557 $349,000
Q3 2021

Nov 01, 2021

BUY
$71.68 - $78.83 $46,592 - $51,239
650 Added 17.07%
4,457 $335,000
Q3 2019

Oct 28, 2019

SELL
$76.08 - $82.93 $111,076 - $121,077
-1,460 Reduced 27.72%
3,807 $320,000
Q4 2018

Jan 30, 2019

SELL
$65.24 - $75.71 $26,095 - $30,283
-400 Reduced 7.06%
5,267 $403,000
Q1 2018

May 09, 2018

BUY
$50.96 - $59.23 $17,071 - $19,842
335 Added 6.28%
5,667 $309,000
Q4 2017

Feb 05, 2018

BUY
$51.62 - $61.64 $5,162 - $6,164
100 Added 1.91%
5,332 $300,000
Q3 2017

Nov 14, 2017

BUY
$58.67 - $63.13 $49,869 - $53,660
850 Added 19.4%
5,232 $335,000
Q2 2017

Aug 07, 2017

BUY
N/A
4,382
4,382 $281,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $284B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Neumann Capital Management, LLC Portfolio

Follow Neumann Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neumann Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neumann Capital Management, LLC with notifications on news.